Literature DB >> 32215607

Controlling Conjunctival Melanoma-To Infinity and Beyond.

Carol L Shields1, Sara E Lally1, Marlana Orloff2.   

Abstract

Entities:  

Year:  2020        PMID： 32215607     DOI： 10.1001/jamaophthalmol.2020.0522

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  1 in total

1.  IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.

Authors:  Dawei Song; Sonia Cismas; Caitrin Crudden; Eric Trocme; Claire Worrall; Naida Suleymanova; Tingting Lin; Huiyuan Zheng; Stefan Seregard; Ada Girnita; Leonard Girnita
Journal:  Oncogene       Date:  2021-11-17       Impact factor: 9.867
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.